1. Lomustine and bevacizumab in progressive glioblastoma;Wick;N Engl J Med,2017
2. Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial;Lombardi;Lancet Oncol,2018
3. Design issues of randomized phase II trials and a proposal for phase II screening trials;Rubinstein;J Clin Oncol,2005
4. Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma;Wick;J Clin Oncol,2010
5. Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma;Batchelor;J Clin Oncol,2013